Clinical Trials Logo

Clinical Trial Summary

Hypertensive disorders of pregnancy are important cause of severe morbidity, long-term disability and death among both mothers and their babies. In Africa and Asia, nearly one tenth of all maternal deaths are associated with hypertensive disorders of pregnancy research has focused on the antenatal complications' for both mother and baby and the risks and benefits of administering antihypertensive therapy prior to delivery hypertension disorders of pregnancy often persist following delivery and sometimes arise de novo postpartum one of the maternal complications of pre eclampsia is residual chronic hypertension in about 1/3 of cases elevated blood pressure is seen in 6%to 8% of all pregnancies hypertension (arterial pressure >140/90 mmhg) in pregnancy is classified into one of four conditions

1. chronic hypertension that precedes pregnancy

2. pre eclampsia and eclampsia: a systematic syndrome of elevated arterial pressure,proteinuria and other findings

3. pre eclampsia superimposed upon chronic hypertension

4. gestational hypertension or nonproteinuric hypertension of pregnancy


Clinical Trial Description

Hypertensive disorders of pregnancy are important cause of severe morbidity, long-term disability and death among both mothers and their babies. In Africa and Asia, nearly one tenth of all maternal deaths are associated with hypertensive disorders of pregnancy research has focused on the antenatal complications' for both mother and baby and the risks and benefits of administering antihypertensive therapy prior to delivery hypertension disorders of pregnancy often persist following delivery and sometimes arise de novo postpartum one of the maternal complications of pre eclampsia is residual chronic hypertension in about 1/3 of cases elevated blood pressure is seen in 6%to 8% of all pregnancies hypertension (arterial pressure >140/90 mmhg) in pregnancy is classified into one of four conditions

1. chronic hypertension that precedes pregnancy

2. pre eclampsia and eclampsia: a systematic syndrome of elevated arterial pressure,proteinuria and other findings

3. pre eclampsia superimposed upon chronic hypertension

4. gestational hypertension or nonproteinuric hypertension of pregnancy evaluate the effectiveness, safety and acceptability of Oral nifedipine versus oral labetalol in treatment of persistent postpartum hypertension ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03449277
Study type Interventional
Source Assiut University
Contact Hossam Ahmed Abd Ellah, MBBCH
Phone 0201119939775
Email drhaaada@gmail.com
Status Recruiting
Phase Phase 4
Start date January 19, 2018
Completion date March 1, 2019

See also
  Status Clinical Trial Phase
Completed NCT04486170 - Assessment of Postpartum Education to Improve Compliance N/A
Completed NCT03613714 - Innovation in Postpartum Care for Women With Hypertensive Disorders of Pregnancy N/A
Completed NCT04752475 - Lasix for the Prevention of De Novo Postpartum Hypertension Phase 3
Active, not recruiting NCT05049616 - Oral Combined Hydrochlorothiazide/Lisinopril Versus Oral Nifedipine for Postpartum Hypertension Phase 4
Recruiting NCT03298802 - Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide Phase 3
Recruiting NCT06310720 - Postpartum Video Education in High Risk Populations N/A
Recruiting NCT05849103 - Comprehensive Postpartum Management for Women With Hypertensive Disorders of Pregnancy N/A
Completed NCT05775744 - Management of Postpartum Preeclampsia N/A
Recruiting NCT05309460 - Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial Phase 4
Completed NCT05159726 - Postpartum Video Education N/A
Completed NCT03749746 - Heart Health 4 New Moms: A Randomized Trial in the First Year After Preeclampsia N/A
Completed NCT04236258 - Comparing Nifedipine and Enalapril in Medical Resources Used in the Postpartum Period Phase 4
Completed NCT04222855 - Efficacy of Diltiazem for the Control of Blood Pressure in Puerperal Patients With Severe Preeclampsia N/A
Not yet recruiting NCT05139238 - Postpartum Hypertension Study Phase 4